Line 757: |
Line 757: |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease|| | + | | B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease||Afia Hasnain + Yassmine Akkari |
− | |
| |
| | | | | |
| | | | | |
| + | |PENDING |
| | ||YA | | | ||YA |
| | | | | |
Line 774: |
Line 774: |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| | + | | B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari |
− | |
| |
| | | | | |
| | | | | |
| + | |PENDING |
| | ||YA | | | ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease|| | + | | B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari |
− | |
| |
| | | | | |
| | | | | |
| + | |PENDING |
| | ||YA | | | ||YA |
| | | | | |
Line 801: |
Line 801: |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| | + | | B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley |
− | |
| |
| | | | | |
| | | | | |
| + | |PENDING |
| | ||YA | | | ||YA |
| | | | | |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| | + | | B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley |
− | |
| |
| | | | | |
| | | | | |
| + | |PENDING |
| | ||YA | | | ||YA |
| | | | | |
Line 826: |
Line 826: |
| | | | | |
| |- | | |- |
− | | B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| | + | | B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||Holli Drendel |
− | |
| |
| | | | | |
| | | | | |
| + | |PENDING |
| | ||YA | | | ||YA |
| | | | | |